STOCKHOLDERS’ EQUITY |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS’ EQUITY | 6. STOCKHOLDERS’ EQUITY
Preferred Stock
During the three months ended March 31, 2023 and March 31, 2022, the Company paid $6,900 and $7,500, respectively for Series D preferred stock dividends. Dividends of $7,500 were declared during the three months ended March 31, 2023 and 2022.
Common Stock
For the three months ended March 31, 2023, the Company did not issue nor did it pay dividends on common stock.
Common Stock Warrants
As of March 31, 2023, and December 31, 2022, the Company had 206,000 of outstanding warrants to purchase common stock at a weighted average exercise price of $5.00 and weighted average remaining term of years and years, respectively. The aggregate intrinsic value of common stock warrants outstanding as of March 31, 2023, and December 31, 2022 was $ . Activity for the three months ended March 31, 2023, related to common stock warrants is as follows:
|